NCT02804334

The Role of Molecules in Blood Cells for Diagnosing Bipolar Disorders

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 29 (actual)
• Sponsor: University Hospitals Cleveland Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The goal of this project is to study \~45 molecules in blood cells that may differentiate patients with bipolar disorder from healthy controls.

Detailed description

There is one study visit for this research protocol. Participants may complete this visit on the day that they sign consent. If there is an upcoming blood draw already scheduled for the participant, within the clinical research trial in which they are enrolled, they may decide to wait until then to receive their blood draw. In addition, if a subject has completed the protocol specific monitoring labs within the past 30 days, either for clinical or research purposes, they do not have to be repeated. After obtaining the informed consent, all potential research participants will be assessed with a systemic clinical interview and a structured interview with the Mini-International Neuropsychiatric Interview (MINI). Psychiatric assessments will be administered to all participants, both healthy controls and participants diagnosed with bipolar disorder (BD). All eligible participants will also complete a Clinical Record Form. The form includes demographics, previous treatment history, the number of previous episodes, family history, and other historical correlates.

Conditions

• Bipolar Disorder

Interventions

Type	Name	Description
PROCEDURE	Psychiatric Questionnaires
PROCEDURE	Blood draw

Timeline

• Start date: 2016-06-01
• Primary completion: 2018-10-01
• Completion: 2018-10-01
• First posted: 2016-06-17
• Last updated: 2018-11-01

Locations

1 site across 1 country: United States